Alrosa to sell rough diamonds here

Alrosa, the second largest rough diamond distributor, will for the first time begin selling rough diamonds directly from its Israel office.

By SHARON WROBEL
January 15, 2007 07:07

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Alrosa, the second largest rough diamond distributor, will for the first time begin selling rough diamonds directly from its Israel office. "There is no doubt that the participation of Alrosa into the business activity of the Israeli Diamond Exchange, will strengthen the Israeli diamond industry and represents a vote of confidence to the Israeli industry," said Avi Paz, President of the Israel Diamond Exchange. Alrosa will launch the first sale of rough diamonds in Israel on January 24 at a total volume of $4 million. From next week, Alrosa rough diamonds, will come into Israel on a regular monthly basis. The Russian diamond distributor generates an annual diamond output of more than $3 billion.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS